ASCO 2018: Choices for front-line NSCLC
With permutations of potential front-line treatments for non-small cell lung cancer (NSCLC) seemingly endless, one thing seems certain…
With permutations of potential front-line treatments for non-small cell lung cancer (NSCLC) seemingly endless, one thing seems certain…
Hot topics in lung cancer – interviews from ASCO 2018.
June 2018 saw the launch of our first edition of LungCancer.Med, a new congress news e-journal containing interviews with speakers and delegates as well as articles on the latest hot… read more.
Patients with moderate-to-severe uncontrolled asthma treated with the ezcema drug dupilumab have achieved significantly lower rates of severe asthma exacerbation than those using a placebo. Researchers reported this… read more.
Researchers from a retrospective, observational study report that victims of flu or pneumonia have a significantly increased risk of heart attack or stroke in the days after their… read more.
Author: Bruce Sylvester Patients with persistent symptomatic asthma had fewer asthma exacerbations and improved quality of life when treated with oral azithromycin for 48 weeks, researchers on August… read more.
by Bruce Sylvester: Treatment of pain and fever with acetaminophen (Tylenol, etc.) does not exacerbate asthma in young children, researchers reported on August 18 NEJM/New England Journal of Medicine.
Parents of children with asthma need ongoing education and guidance on this chronic condition and how to prevent and manage symptoms, but does a written asthma action plan… read more.
New research presented at Euroanaesthesia 2016 (London 27-30 May) shows that patients undergoing breast cancer surgery need less painkilling medication post-surgery if they have anaesthesia that is free… read more.
by Bruce Sylvester: There is no decrease in hospital length of stay among patients hospitalized with acute respiratory failure who have received standardized rehabilitation therapy rather than usual… read more.
by Bruce Sylvester: Persistent, very poorly controlled (VPC) disease remains highly prevalent after 10 years of standard treatment among patients with severe or difficult-to-treat asthma, researchers reported on… read more.
by Bruce Sylvester: Treatment with cardioselective beta-blockers appears to reduce the risk of exacerbations in chronic obstructive pulmonary disease (COPD), and it is especially effective in preventing COPD… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.